WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexeo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard Nolan TownsendChief Executive Officer2025-05-161,074$2.77
$2.98kSell
Tai Sandi SeeChief Development Officer2025-05-16367$2.77
$1.02kSell
Eric AdlerChief Medical Officer2025-05-16585$2.77
$1.62kSell
Jenny RobertsonChief Legal Officer2025-05-16521$2.77
$1.45kSell
Tai Sandi SeeChief Development Officer2025-03-145,720$2.61
$14.93kBuy
Jenny RobertsonChief Legal Officer2025-03-145,720$2.61
$14.93kBuy
Richard Nolan TownsendChief Executive Officer2025-03-142,128$2.61
$5.55kBuy
Jose Manuel OteroChief Technical Officer2025-03-145,720$2.61
$14.93kBuy
Eric AdlerChief Medical Officer2025-02-192,359$4.41
$10.41kSell
Jenny RobertsonChief Legal Officer2025-02-192,101$4.41
$9.27kSell

1 of 3

LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXEO insiders and whales buy or sell their stock.

LXEO Shareholders

What type of owners hold Lexeo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC13.73%4,557,920$17.96MInstitution
Citadel Advisors LLC8.20%2,723,363$10.73MInstitution
Longitude Capital Partners IV LLC7.73%2,567,100$10.11MInsider
Omega Fund VI LP6.50%2,157,623$8.50MInsider
Blackrock Inc5.55%1,842,232$7.26MInstitution
Invest A. Lundbeckfond5.53%1,835,959$7.23MInsider
Affinity Asset Advisors LLC4.46%1,480,881$5.83MInstitution
Omega Fund Management LLC3.57%1,184,636$4.67MInstitution
Blackstone Inc3.49%1,158,617$4.56MInstitution
Vestal Point Capital LP3.42%1,136,249$4.48MInstitution

1 of 3

LXEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXEO79.72%20.28%Net SellingNet Selling
BDTX66.91%33.09%Net SellingNet Selling
NKTX63.53%36.47%Net Selling
AGEN6.06%93.94%Net BuyingNet Buying
ASMB24.27%75.73%Net BuyingNet Selling
View Top Biotech Stocks

Lexeo Therapeutics Stock Ownership FAQ

Who owns Lexeo Therapeutics?

Lexeo Therapeutics (NASDAQ: LXEO) is owned by 84.37% institutional shareholders, 21.46% Lexeo Therapeutics insiders, and 0.00% retail investors. Longitude Capital Partners IV LLC is the largest individual Lexeo Therapeutics shareholder, owning 2.57M shares representing 7.73% of the company. Longitude Capital Partners IV LLC's Lexeo Therapeutics shares are currently valued at $10.11M.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.